SOURCE: The Bedford Report

The Bedford Report

August 24, 2011 08:16 ET

Regulatory Headwinds Lead Altria and Star Scientific to New Revenue Drivers

The Bedford Report Provides Equity Research on Altria and Star Scientific

NEW YORK, NY--(Marketwire - Aug 24, 2011) - Stocks throughout the cigarette industry are exceptionally volatile of late. While traditional cigarette companies are facing heightened FDA regulation, non-traditional tobacco products and smoking cessation products are facing less scrutiny. The Bedford Report examines the outlook for companies in the Cigarette Industry and provides investment research on Altria Group, Inc. (NYSE: MO) and Star Scientific, Inc. (NASDAQ: CIGX). Access to the full company reports can be found at:

The Food and Drug Administration (FDA) law that would force tobacco companies to place graphic health images on cigarette packs is facing severe opposition from cigarette manufacturers. The new warnings will be required on all cigarette packs beginning in September 2012. As many as five tobacco companies are suing the FDA over the new law, saying that it violates their constitutional right to free speech as it would require them to promote the government's anti-smoking message.

The Bedford Report releases stock research on the Cigarette Industry so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at and get exclusive access to our numerous analyst reports and industry newsletters.

With increasing regulatory pressures, companies in the sector are looking to transition into different smokeless tobacco products. Revenue for smokeless products grew 11 percent in 2010. Presently, Altria offers smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands. Though chewing tobacco has been associated with various oral ailments, it is considered by some to be less hazardous than smoking and isn't as tightly regulated.

Some companies, like Star Scientific, are even looking in the direction of health care as a way through the secular shift away from combustible tobacco products. Star Scientific makes two dissolvable tobacco lozenges, Ariva and Stonewell, which are not subject to Chapter IX of Federal Food Drug & Cosmetic Act.

The Bedford Report provides Market Research focused on equities that offer growth opportunities, value, and strong potential return. We strive to provide the most up-to-date market activities. We constantly create research reports and newsletters for our members. The Bedford Report has not been compensated by any of the above-mentioned publicly traded companies. The Bedford Report is compensated by other third party organizations for advertising services. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at

Contact Information